CEO
Drug Hunter Inc.
Dennis started Drug Hunter (drughunter.com) because he felt time-constrained drug discovery professionals needed a science-focused, easy-to-read information source that balanced the relevance of industry news with the credibility of academic journals. Before founding Drug Hunter as its CEO and Editor-in-Chief, he started his career as a drug discovery scientist at a now publicly-listed biotech startup (RAPT), where he contributed to the discovery of a phase II drug candidate for cancer immunotherapy. He later joined Genentech, a subsidiary of Roche, the largest pharmaceutical company in the world by revenue. He has been a chemistry and project team leader for several projects leading to patented and published chemical matter. He earned his PhD in Chemistry from Stanford University, MPhil by Research from the University of Cambridge on a Churchill Scholarship, and a dual BA/MS from Northwestern University as a Goldwater Scholar.
Disclosure information not submitted.
Wednesday, October 19, 2022
8:30 AM – 9:00 AM ET
Wednesday, October 19, 2022
9:00 AM – 10:30 AM ET